ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma

ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma

Yanjiao Mao, Shixiu Wu Department of Radiotherapy Oncology, Hangzhou Cancer Hospital, Hangzhou, People’s Republic of China Purpose: The purpose of this study was to explore the frequencies of ALK and ROS1 fusion genes in EGFR-mutant lung adenocarcinoma patients and examine the therapeuti...

Full description

Bibliographic Details
Main Authors: Mao Y, Wu S
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:OncoTargets and Therapy
Subjects:
Epidermal growth factor receptor
ALK
ROS1
Lung adenocarcinoma
Efficacy
Online Access:https://www.dovepress.com/alk-and-ros1-concurrent-with-egfr-mutation-in-patients-with-lung-adeno-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/alk-and-ros1-concurrent-with-egfr-mutation-in-patients-with-lung-adeno-peer-reviewed-article-OTT

Similar Items